Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion type Assertion NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_head.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion description "[Treatment with oncostatin M (OSM), interleukin (IL)-1 and tumor necrosis factor (TNF)-alpha induced the expression of 18, 22 and 24 kDa bFGF isoforms in KS and human umbilical vein endothelial cells (HUVEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion evidence source_evidence_literature NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion SIO_000772 9456251 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion wasDerivedFrom befree-20140225 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion wasGeneratedBy ECO_0000203 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.